Latest Software As A Service News

Connexion Mobility Ltd reported a 7% rise in revenues and a 5% increase in profit after tax for the half-year ended December 2025, while expanding its SaaS footprint and acquiring a strategic stake in Covertrue Group.

Bailador Technology Investments reports a 33% rise in net profit for HY26 and declares a fully-franked interim dividend, underpinned by robust portfolio company valuations and cash realisations.

X2M Connect Limited reported a robust first half of FY26 with a 45% revenue increase and significant contract wins in Asia, positioning the company for sustained growth.

Codeifai Limited has raised $1.1 million through a share placement that coincided with a sharp increase in its share price, confirming full compliance with ASX disclosure rules following a detailed inquiry.

DataWorks has secured a significant contract extension with iGaming Ontario, adding over C$12.5 million to its Centralised Self-Exclusion program services. This move strengthens its recurring revenue and solidifies its RegTech division’s profitability.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

A handful of small caps ripped higher, but plenty still slipped even after good news. This week’s biggest moves came from a platform partnership win, a reinstated stock, and a cash settlement that removed a long-running dispute.

CL8 Holdings has sharply reduced expenses following office closure and is actively exploring new growth sectors including AI, B2B SaaS, EdTech, and Cybersecurity while maintaining its stake in the expanding car subscription market.

IMEXHS Limited has reported a strong finish to FY25, delivering revenue and underlying EBITDA at the top end of its guidance, driven by robust software growth and expanding recurring revenue.

4DMedical has secured a commercial contract with University of Chicago Medicine to deploy its CT, VQ™ lung imaging technology, marking the fifth major US academic medical centre to adopt the platform since FDA clearance.

PainChek has secured FDA De Novo clearance, enabling entry into the vast US healthcare market with a $3 billion Remote Therapeutic Monitoring opportunity. The company reports $5.6 million contracted ARR and a strong global footprint in aged care.